{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:14:22Z","timestamp":1790795662191,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010992","name":"Transplantation Society of Australia and New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015675","name":"National Blood Authority Australia","doi-asserted-by":"publisher","award":["IgP02"],"award-info":[{"award-number":["IgP02"]}],"id":[{"id":"10.13039\/100015675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.kint.2025.04.023","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:14:46Z","timestamp":1747941286000},"page":"470-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5109-165X","authenticated-orcid":false,"given":"William R.","family":"Mulley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0753-1272","authenticated-orcid":false,"given":"Dhakshayini","family":"Tharmaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-002X","authenticated-orcid":false,"given":"Kevan R.","family":"Polkinghorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-3092","authenticated-orcid":false,"given":"Greg H.","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhpal K.","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0989-7136","authenticated-orcid":false,"given":"Edward","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2085-9851","authenticated-orcid":false,"given":"Moshe","family":"Olshansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3771-9102","authenticated-orcid":false,"given":"Darren","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7637-3661","authenticated-orcid":false,"given":"Peter F.","family":"Mount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-7269","authenticated-orcid":false,"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-7200","authenticated-orcid":false,"given":"Kate R.","family":"Wyburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3410-3572","authenticated-orcid":false,"given":"Wai H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3178-849X","authenticated-orcid":false,"given":"Peter G.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-2931","authenticated-orcid":false,"given":"David J.","family":"Nikolic-Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-5955","authenticated-orcid":false,"given":"John","family":"Kanellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.04.023_bib1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/nep.14397","article-title":"Defining causes of death-censored kidney allograft failure: a 5-year multicentre ANZDATA and clinical cross-sectional study","volume":"29","author":"Mulley","year":"2024","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2025.04.023_bib2","article-title":"Causes of kidney graft failure in a cohort of recipients with a very long-time follow-up after transplantation","volume":"9","author":"Betjes","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.kint.2025.04.023_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162278","article-title":"The spectrum of renal allograft failure","volume":"11","author":"Chand","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2025.04.023_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib5","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1681\/ASN.2020081215","article-title":"Exploring the complexity of death-censored kidney allograft failure","volume":"32","author":"Mayrdorfer","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.023_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001273","article-title":"Death with function and graft failure after kidney transplantation: risk factors at baseline suggest new approaches to management","volume":"8","author":"Merzkani","year":"2022","journal-title":"Transplant Direct"},{"key":"10.1016\/j.kint.2025.04.023_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/TP.0000000000000183","article-title":"The histology of kidney transplant failure: a long-term follow-up study","volume":"98","author":"Naesens","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib9","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1097\/TP.0000000000003192","article-title":"Assessing the complex causes of kidney allograft loss","volume":"104","author":"Van Loon","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib10","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib11","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1097\/TP.0000000000004700","article-title":"Early versus late acute AMR in kidney transplant recipients\u2014a comparison of treatment approaches and outcomes from the ANZDATA registry","volume":"107","author":"Fernando","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TP.0000000000003095","article-title":"Recommended treatment of antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantation society working group","volume":"104","author":"Schinstock","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000002049","article-title":"The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis","volume":"102","author":"Wan","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1681\/ASN.2020071106","article-title":"A randomized clinical trial of anti-IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection","volume":"32","author":"Doberer","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.023_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.023_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.023_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ajt.14520","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial","volume":"18","author":"Moreso","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199402270-00014","article-title":"Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ","volume":"57","author":"Tyan","year":"1994","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.kint.2025.04.023_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13037","article-title":"Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab","volume":"31","author":"Mulley","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2025.04.023_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/MOT.0000000000000250","article-title":"Intravenous immunoglobulin in kidney transplantation","volume":"20","author":"Tedla","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1440-1797.2010.01399.x","article-title":"Slow and steady. Reducing thrombotic events in renal transplant recipients treated with IVIg for antibody-mediated rejection","volume":"16","author":"Huang","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2025.04.023_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ki.1992.21","article-title":"Histopathological findings in well-functioning, long-term renal allografts","volume":"41","author":"Isoniemi","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.023_bib27","first-page":"1195","article-title":"Histological chronic allograft damage index accurately predicts chronic renal allograft rejection","volume":"58","author":"Isoniemi","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib28","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/ajt.16059","article-title":"Banff 2019 Meeting Report: molecular diagnostics in solid organ transplantation\u2014Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation","volume":"20","author":"Mengel","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18+ years","volume":"91","author":"Rubin","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.kint.2025.04.023_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.kint.2022.09.030","article-title":"A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection","volume":"103","author":"Haas","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.023_bib31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/TP.0000000000005336","article-title":"Toward activity and chronicity indices for the evaluation of kidney transplant rejection: a viewpoint by the Banff Working Group","volume":"109","author":"Naesens","year":"2025","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181251","article-title":"High-resolution physicochemical characterization of different intravenous immunoglobulin products","volume":"12","author":"Washburn","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2025.04.023_bib33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/ajt.14001","article-title":"Eculizumab therapy for chronic antibody-mediated injury in kidney transplant recipients: a pilot randomized controlled trial","volume":"17","author":"Kulkarni","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajt.2023.12.005","article-title":"Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation","volume":"24","author":"Diebold","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib35","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.kint.2023.04.015","article-title":"Application of the Banff Human Organ Transplant Panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection","volume":"104","author":"Beadle","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.023_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000004624","article-title":"The molecular phenotype of kidney transplants: insights from the MMDx Project","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1681\/ASN.2017050589","article-title":"Complement-activating anti-HLA antibodies in kidney transplantation: allograft gene expression profiling and response to treatment","volume":"29","author":"Lefaucheur","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.023_bib39","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/ndt\/gfab231","article-title":"Diagnostic application of transcripts associated with antibody-mediated rejection in kidney transplant biopsies","volume":"37","author":"Toulza","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.023_bib40","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.023_bib41","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.TP.0000443226.74584.03","article-title":"High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction","volume":"97","author":"Cooper","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2025.04.023_bib42","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1038\/s41467-021-24615-6","article-title":"Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection","volume":"12","author":"Asano","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.04.023_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa035588","article-title":"Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling","volume":"349","author":"Sarwal","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.023_bib44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2016.00646","article-title":"Lymphoid neogenesis and tertiary lymphoid organs in transplanted organs","volume":"7","author":"Koenig","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2025.04.023_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.kint.2025.04.023_bib46","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.neuroscience.2008.07.015","article-title":"Neuroprotection in stroke by complement inhibition and immunoglobulin therapy","volume":"158","author":"Arumugam","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.kint.2025.04.023_bib47","article-title":"Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke","volume":"4","author":"Fann","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.kint.2025.04.023_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825004065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825004065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:41:20Z","timestamp":1762231280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825004065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0085253825004065"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.04.023","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.05.034","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}